在制药公司网站上评估临床试验内容对患者的可读性
1, Cambridge, UK. christopher.felix.brewer@gmail.com.
Pharmaceutical medicine
|December 15, 2025
概括
制药公司的网站往往呈现的临床试验信息太复杂,患者无法理解. 提高可读性对于公平获取和参与研究的知情决策至关重要.
科学领域:
- 临床研究和制药科学.
- 健康沟通和患者参与.
- 健康素养和可访问性.
背景情况:
- 有效的患者招募和注册对于成功的临床试验至关重要.
- 制药公司在提供可访问的患者信息方面发挥着关键作用.
- 全球卫生组织建议患者材料应达到11-12岁的识字水平.
研究的目的:
- 评估药品公司网站上临床试验信息的可用性.
- 为了评估这种面向患者的内容的可读性.
- 为了比较全球,英国,加拿大和澳大利亚制药网站的内容.
主要方法:
- 根据市值,分析了全球30家最大的制药公司的网站.
- 审查的临床试验内容可用性.
- 应用了三个经过验证的可读性指标:弗莱什-金凯德等级 (FKG),弗莱什阅读方便度得分 (FRES) 和简单的测量Gobbledygook (SMOG).
主要成果:
- 虽然96%的全球网站有试验信息,55%的非全球网站缺乏或仅在外部链接.
- 可读性得分表明高中到大学水平的复杂性 (例如,FKG平均为全球10.9,英国14.2).
- SMOG得分表明,需要13-15年的教育才能理解.
结论:
- 药品网站上的临床试验信息经常难以阅读,并且超过了推的识字水平.
- 阅读能力差对于文盲程度较低,英语水平有限或残疾的人来说,创造了障碍,导致不平等.
- 采用简单的语言原则可以提高可访问性,并支持患者对临床试验参与的知情决策.
相关概念视频
01:11Clinical Trials: Overview
4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
01:16Clinical Trials
10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.1K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
380
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
380
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
133
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
133
01:26Drug Administration and Therapy Phases: Overview
1.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K
01:12Hazard Ratio
549
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
549